12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Company News  |  Other News

Aveva Drug Delivery Systems, BioDelivery, MonoSol Rx, Meda neurology , drug delivery news

MonoSol said that it will submit a response to a non-final action issued by the U.S. Patent & Trademark Office (PTO) last month rejecting all claims of its U.S. Patent No. 7,425,292 covering methods of making drug-containing films. The action accompanied the PTO's order granting an instant ex parte reexamination of the patent as requested by BioDelivery in January. The deadline for MonoSol's response is two months from Feb. 16. According to MonoSol,...

Read the full 343 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >